Global Vaccine Delivery Devices

Vaccine Delivery Devices Comprehensive Study by Type (Syringes, Jet Injectors, Other Devices), Application (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, Others), Administration (Orally, Injected, Intra muscularly), End User (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2027

Vaccine Delivery Devices Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Vaccine Delivery Devices?
Vaccine delivery devices are utilized for the therapy of a few several sicknesses and infections. Vaccines are natural material biological shields people from diseases brought about by microbes and infections. The different types of vaccines include live vaccine, inactivated vaccine, toxoid vaccine, and conjugate vaccine. Vaccine delivery devices are specialized devices that deliver a dose of a drug or vaccine through a particular route of administration. Immunization through vaccines is done to raise the immune response leading to the generation of antibodies or cell-mediated responses that would combat infectious agents or any noninfectious conditions. The most critical factor for successful immunization is to choose the route of administration by which a vaccine is bought into contact with the body. The vaccine delivery system aids to lower the spread of infection, enhance the efficiency of vaccine administration, and increase disease management by evoking better immune responses. As per the Centers for Disease Control and Prevention around 385,000 serious injuries containing needle-stick wounds happen each year in emergency clinics in the U.S. Likewise, these gadgets are additionally progressively utilized among diabetic patients to infuse portions of insulin, for example, Novorapid and Lantus. Aside from infusing sedation prior to starting with an activity, the antibody conveyance gadgets expand their application for different medicines in the medical services industry.

The market study is broken down by Type (Syringes, Jet Injectors and Other Devices), by Application (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination and Others) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Vaccine Delivery Devices market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

PharmaJet, Inc. (United States), Vaxxas (United States), Gerresheimer AG(Germany), Schott AG (Germany), 3M (United States), Corium International, Inc. (United States), Becton Dickinson & Company (United States) and Bioject Medical Technologies, Inc. (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Vaccine Delivery Devices market by Type, Application and Region.

On the basis of geography, the market of Vaccine Delivery Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Administration , the sub-segment i.e. Orally will boost the Vaccine Delivery Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Vaccine Delivery Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

In May 2020 3M Drug Delivery Systems relaunches as Kindeva Drug Delivery Kindeva Drug Delivery, some time ago 3M Drug Delivery Systems, declared on May 1, 2020, that it is dispatching as an autonomous organization after a securing by Altaris Capital Partners for USD650 million. Under the details of the arrangement, 3D will hold a 17% minority premium in Kindeva close by Altaris, an organization official statement said. Kindeva is an agreement advancement and assembling association for complex medication conveyance, including transdermal patches, microneedle-based innovations, and metered-portion inhalers.


Market Trend
  • Rising acceptance of the needle-free method

Market Drivers
  • Increasing knowledge to avoid injuries and pain associated with the usage of a needle stick
  • Unhealthy lifestyle and growth in the aging population

Opportunities
  • Increasing adoption from the Asia Pacific region due to the large patient pool and target population is booming the growth opportunities in the market


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Vaccine Delivery Devices Providers, Enteric Softgel Capsules Manufacturer, Government Regulatory and Research Organizations and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Syringes
  • Jet Injectors
  • Other Devices
By Application
  • Intradermal Vaccination
  • Intramuscular Vaccination
  • Subcutaneous Vaccination
  • Others
By Administration
  • Orally
  • Injected
  • Intra muscularly

By End User
  • Hospitals
  • Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing knowledge to avoid injuries and pain associated with the usage of a needle stick
      • 3.2.2. Unhealthy lifestyle and growth in the aging population
    • 3.3. Market Trends
      • 3.3.1. Rising acceptance of the needle-free method
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Vaccine Delivery Devices, by Type, Application, Administration , End User and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Vaccine Delivery Devices (Value)
      • 5.2.1. Global Vaccine Delivery Devices by: Type (Value)
        • 5.2.1.1. Syringes
        • 5.2.1.2. Jet Injectors
        • 5.2.1.3. Other Devices
      • 5.2.2. Global Vaccine Delivery Devices by: Application (Value)
        • 5.2.2.1. Intradermal Vaccination
        • 5.2.2.2. Intramuscular Vaccination
        • 5.2.2.3. Subcutaneous Vaccination
        • 5.2.2.4. Others
      • 5.2.3. Global Vaccine Delivery Devices by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Others
      • 5.2.4. Global Vaccine Delivery Devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Vaccine Delivery Devices (Volume)
      • 5.3.1. Global Vaccine Delivery Devices by: Type (Volume)
        • 5.3.1.1. Syringes
        • 5.3.1.2. Jet Injectors
        • 5.3.1.3. Other Devices
      • 5.3.2. Global Vaccine Delivery Devices by: Application (Volume)
        • 5.3.2.1. Intradermal Vaccination
        • 5.3.2.2. Intramuscular Vaccination
        • 5.3.2.3. Subcutaneous Vaccination
        • 5.3.2.4. Others
      • 5.3.3. Global Vaccine Delivery Devices by: End User (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Clinics
        • 5.3.3.3. Others
      • 5.3.4. Global Vaccine Delivery Devices Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Vaccine Delivery Devices (Price)
      • 5.4.1. Global Vaccine Delivery Devices by: Type (Price)
  • 6. Vaccine Delivery Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. PharmaJet, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Vaxxas (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Gerresheimer AG(Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Schott AG (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. 3M (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Corium International, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Becton Dickinson & Company (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bioject Medical Technologies, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Vaccine Delivery Devices Sale, by Type, Application, Administration , End User and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Vaccine Delivery Devices (Value)
      • 7.2.1. Global Vaccine Delivery Devices by: Type (Value)
        • 7.2.1.1. Syringes
        • 7.2.1.2. Jet Injectors
        • 7.2.1.3. Other Devices
      • 7.2.2. Global Vaccine Delivery Devices by: Application (Value)
        • 7.2.2.1. Intradermal Vaccination
        • 7.2.2.2. Intramuscular Vaccination
        • 7.2.2.3. Subcutaneous Vaccination
        • 7.2.2.4. Others
      • 7.2.3. Global Vaccine Delivery Devices by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Others
      • 7.2.4. Global Vaccine Delivery Devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Vaccine Delivery Devices (Volume)
      • 7.3.1. Global Vaccine Delivery Devices by: Type (Volume)
        • 7.3.1.1. Syringes
        • 7.3.1.2. Jet Injectors
        • 7.3.1.3. Other Devices
      • 7.3.2. Global Vaccine Delivery Devices by: Application (Volume)
        • 7.3.2.1. Intradermal Vaccination
        • 7.3.2.2. Intramuscular Vaccination
        • 7.3.2.3. Subcutaneous Vaccination
        • 7.3.2.4. Others
      • 7.3.3. Global Vaccine Delivery Devices by: End User (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Clinics
        • 7.3.3.3. Others
      • 7.3.4. Global Vaccine Delivery Devices Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Vaccine Delivery Devices (Price)
      • 7.4.1. Global Vaccine Delivery Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Vaccine Delivery Devices: by Type(USD Million)
  • Table 2. Vaccine Delivery Devices Syringes , by Region USD Million (2016-2021)
  • Table 3. Vaccine Delivery Devices Jet Injectors , by Region USD Million (2016-2021)
  • Table 4. Vaccine Delivery Devices Other Devices , by Region USD Million (2016-2021)
  • Table 5. Vaccine Delivery Devices: by Application(USD Million)
  • Table 6. Vaccine Delivery Devices Intradermal Vaccination , by Region USD Million (2016-2021)
  • Table 7. Vaccine Delivery Devices Intramuscular Vaccination , by Region USD Million (2016-2021)
  • Table 8. Vaccine Delivery Devices Subcutaneous Vaccination , by Region USD Million (2016-2021)
  • Table 9. Vaccine Delivery Devices Others , by Region USD Million (2016-2021)
  • Table 10. Vaccine Delivery Devices: by End User(USD Million)
  • Table 11. Vaccine Delivery Devices Hospitals , by Region USD Million (2016-2021)
  • Table 12. Vaccine Delivery Devices Clinics , by Region USD Million (2016-2021)
  • Table 13. Vaccine Delivery Devices Others , by Region USD Million (2016-2021)
  • Table 14. South America Vaccine Delivery Devices, by Country USD Million (2016-2021)
  • Table 15. South America Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 16. South America Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 17. South America Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 18. South America Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 19. Brazil Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 20. Brazil Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 21. Brazil Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 22. Brazil Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 23. Argentina Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 24. Argentina Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 25. Argentina Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 26. Argentina Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 27. Rest of South America Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 28. Rest of South America Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 29. Rest of South America Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 30. Rest of South America Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 31. Asia Pacific Vaccine Delivery Devices, by Country USD Million (2016-2021)
  • Table 32. Asia Pacific Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 33. Asia Pacific Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 34. Asia Pacific Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 35. Asia Pacific Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 36. China Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 37. China Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 38. China Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 39. China Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 40. Japan Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 41. Japan Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 42. Japan Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 43. Japan Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 44. India Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 45. India Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 46. India Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 47. India Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 48. South Korea Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 49. South Korea Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 50. South Korea Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 51. South Korea Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 52. Taiwan Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 53. Taiwan Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 54. Taiwan Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 55. Taiwan Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 56. Australia Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 57. Australia Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 58. Australia Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 59. Australia Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 60. Rest of Asia-Pacific Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 61. Rest of Asia-Pacific Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 62. Rest of Asia-Pacific Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 63. Rest of Asia-Pacific Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 64. Europe Vaccine Delivery Devices, by Country USD Million (2016-2021)
  • Table 65. Europe Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 66. Europe Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 67. Europe Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 68. Europe Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 69. Germany Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 70. Germany Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 71. Germany Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 72. Germany Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 73. France Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 74. France Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 75. France Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 76. France Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 77. Italy Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 78. Italy Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 79. Italy Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 80. Italy Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 81. United Kingdom Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 82. United Kingdom Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 83. United Kingdom Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 84. United Kingdom Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 85. Netherlands Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 86. Netherlands Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 87. Netherlands Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 88. Netherlands Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 89. Rest of Europe Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 90. Rest of Europe Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 91. Rest of Europe Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 92. Rest of Europe Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 93. MEA Vaccine Delivery Devices, by Country USD Million (2016-2021)
  • Table 94. MEA Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 95. MEA Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 96. MEA Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 97. MEA Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 98. Middle East Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 99. Middle East Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 100. Middle East Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 101. Middle East Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 102. Africa Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 103. Africa Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 104. Africa Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 105. Africa Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 106. North America Vaccine Delivery Devices, by Country USD Million (2016-2021)
  • Table 107. North America Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 108. North America Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 109. North America Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 110. North America Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 111. United States Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 112. United States Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 113. United States Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 114. United States Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 115. Canada Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 116. Canada Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 117. Canada Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 118. Canada Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 119. Mexico Vaccine Delivery Devices, by Type USD Million (2016-2021)
  • Table 120. Mexico Vaccine Delivery Devices, by Application USD Million (2016-2021)
  • Table 121. Mexico Vaccine Delivery Devices, by Administration USD Million (2016-2021)
  • Table 122. Mexico Vaccine Delivery Devices, by End User USD Million (2016-2021)
  • Table 123. Vaccine Delivery Devices Sales: by Type(K Units)
  • Table 124. Vaccine Delivery Devices Sales Syringes , by Region K Units (2016-2021)
  • Table 125. Vaccine Delivery Devices Sales Jet Injectors , by Region K Units (2016-2021)
  • Table 126. Vaccine Delivery Devices Sales Other Devices , by Region K Units (2016-2021)
  • Table 127. Vaccine Delivery Devices Sales: by Application(K Units)
  • Table 128. Vaccine Delivery Devices Sales Intradermal Vaccination , by Region K Units (2016-2021)
  • Table 129. Vaccine Delivery Devices Sales Intramuscular Vaccination , by Region K Units (2016-2021)
  • Table 130. Vaccine Delivery Devices Sales Subcutaneous Vaccination , by Region K Units (2016-2021)
  • Table 131. Vaccine Delivery Devices Sales Others , by Region K Units (2016-2021)
  • Table 132. Vaccine Delivery Devices Sales: by End User(K Units)
  • Table 133. Vaccine Delivery Devices Sales Hospitals , by Region K Units (2016-2021)
  • Table 134. Vaccine Delivery Devices Sales Clinics , by Region K Units (2016-2021)
  • Table 135. Vaccine Delivery Devices Sales Others , by Region K Units (2016-2021)
  • Table 136. South America Vaccine Delivery Devices Sales, by Country K Units (2016-2021)
  • Table 137. South America Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 138. South America Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 139. South America Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 140. South America Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 141. Brazil Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 142. Brazil Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 143. Brazil Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 144. Brazil Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 145. Argentina Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 146. Argentina Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 147. Argentina Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 148. Argentina Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 149. Rest of South America Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 150. Rest of South America Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 151. Rest of South America Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 152. Rest of South America Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 153. Asia Pacific Vaccine Delivery Devices Sales, by Country K Units (2016-2021)
  • Table 154. Asia Pacific Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 155. Asia Pacific Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 156. Asia Pacific Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 157. Asia Pacific Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 158. China Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 159. China Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 160. China Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 161. China Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 162. Japan Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 163. Japan Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 164. Japan Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 165. Japan Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 166. India Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 167. India Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 168. India Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 169. India Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 170. South Korea Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 171. South Korea Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 172. South Korea Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 173. South Korea Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 174. Taiwan Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 175. Taiwan Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 176. Taiwan Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 177. Taiwan Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 178. Australia Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 179. Australia Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 180. Australia Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 181. Australia Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 182. Rest of Asia-Pacific Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 183. Rest of Asia-Pacific Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 184. Rest of Asia-Pacific Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 185. Rest of Asia-Pacific Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 186. Europe Vaccine Delivery Devices Sales, by Country K Units (2016-2021)
  • Table 187. Europe Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 188. Europe Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 189. Europe Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 190. Europe Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 191. Germany Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 192. Germany Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 193. Germany Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 194. Germany Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 195. France Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 196. France Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 197. France Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 198. France Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 199. Italy Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 200. Italy Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 201. Italy Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 202. Italy Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 203. United Kingdom Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 204. United Kingdom Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 205. United Kingdom Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 206. United Kingdom Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 207. Netherlands Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 208. Netherlands Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 209. Netherlands Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 210. Netherlands Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 211. Rest of Europe Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 212. Rest of Europe Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 213. Rest of Europe Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 214. Rest of Europe Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 215. MEA Vaccine Delivery Devices Sales, by Country K Units (2016-2021)
  • Table 216. MEA Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 217. MEA Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 218. MEA Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 219. MEA Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 220. Middle East Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 221. Middle East Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 222. Middle East Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 223. Middle East Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 224. Africa Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 225. Africa Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 226. Africa Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 227. Africa Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 228. North America Vaccine Delivery Devices Sales, by Country K Units (2016-2021)
  • Table 229. North America Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 230. North America Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 231. North America Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 232. North America Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 233. United States Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 234. United States Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 235. United States Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 236. United States Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 237. Canada Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 238. Canada Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 239. Canada Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 240. Canada Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 241. Mexico Vaccine Delivery Devices Sales, by Type K Units (2016-2021)
  • Table 242. Mexico Vaccine Delivery Devices Sales, by Application K Units (2016-2021)
  • Table 243. Mexico Vaccine Delivery Devices Sales, by Administration K Units (2016-2021)
  • Table 244. Mexico Vaccine Delivery Devices Sales, by End User K Units (2016-2021)
  • Table 245. Vaccine Delivery Devices: by Type(USD/Units)
  • Table 246. Company Basic Information, Sales Area and Its Competitors
  • Table 247. Company Basic Information, Sales Area and Its Competitors
  • Table 248. Company Basic Information, Sales Area and Its Competitors
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Vaccine Delivery Devices: by Type(USD Million)
  • Table 255. Vaccine Delivery Devices Syringes , by Region USD Million (2022-2027)
  • Table 256. Vaccine Delivery Devices Jet Injectors , by Region USD Million (2022-2027)
  • Table 257. Vaccine Delivery Devices Other Devices , by Region USD Million (2022-2027)
  • Table 258. Vaccine Delivery Devices: by Application(USD Million)
  • Table 259. Vaccine Delivery Devices Intradermal Vaccination , by Region USD Million (2022-2027)
  • Table 260. Vaccine Delivery Devices Intramuscular Vaccination , by Region USD Million (2022-2027)
  • Table 261. Vaccine Delivery Devices Subcutaneous Vaccination , by Region USD Million (2022-2027)
  • Table 262. Vaccine Delivery Devices Others , by Region USD Million (2022-2027)
  • Table 263. Vaccine Delivery Devices: by End User(USD Million)
  • Table 264. Vaccine Delivery Devices Hospitals , by Region USD Million (2022-2027)
  • Table 265. Vaccine Delivery Devices Clinics , by Region USD Million (2022-2027)
  • Table 266. Vaccine Delivery Devices Others , by Region USD Million (2022-2027)
  • Table 267. South America Vaccine Delivery Devices, by Country USD Million (2022-2027)
  • Table 268. South America Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 269. South America Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 270. South America Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 271. South America Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 272. Brazil Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 273. Brazil Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 274. Brazil Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 275. Brazil Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 276. Argentina Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 277. Argentina Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 278. Argentina Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 279. Argentina Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 280. Rest of South America Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 281. Rest of South America Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 282. Rest of South America Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 283. Rest of South America Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 284. Asia Pacific Vaccine Delivery Devices, by Country USD Million (2022-2027)
  • Table 285. Asia Pacific Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 286. Asia Pacific Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 287. Asia Pacific Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 288. Asia Pacific Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 289. China Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 290. China Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 291. China Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 292. China Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 293. Japan Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 294. Japan Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 295. Japan Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 296. Japan Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 297. India Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 298. India Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 299. India Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 300. India Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 301. South Korea Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 302. South Korea Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 303. South Korea Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 304. South Korea Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 305. Taiwan Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 306. Taiwan Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 307. Taiwan Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 308. Taiwan Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 309. Australia Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 310. Australia Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 311. Australia Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 312. Australia Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 313. Rest of Asia-Pacific Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 314. Rest of Asia-Pacific Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 315. Rest of Asia-Pacific Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 316. Rest of Asia-Pacific Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 317. Europe Vaccine Delivery Devices, by Country USD Million (2022-2027)
  • Table 318. Europe Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 319. Europe Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 320. Europe Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 321. Europe Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 322. Germany Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 323. Germany Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 324. Germany Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 325. Germany Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 326. France Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 327. France Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 328. France Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 329. France Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 330. Italy Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 331. Italy Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 332. Italy Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 333. Italy Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 334. United Kingdom Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 335. United Kingdom Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 336. United Kingdom Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 337. United Kingdom Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 338. Netherlands Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 339. Netherlands Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 340. Netherlands Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 341. Netherlands Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 342. Rest of Europe Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 343. Rest of Europe Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 344. Rest of Europe Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 345. Rest of Europe Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 346. MEA Vaccine Delivery Devices, by Country USD Million (2022-2027)
  • Table 347. MEA Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 348. MEA Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 349. MEA Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 350. MEA Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 351. Middle East Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 352. Middle East Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 353. Middle East Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 354. Middle East Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 355. Africa Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 356. Africa Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 357. Africa Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 358. Africa Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 359. North America Vaccine Delivery Devices, by Country USD Million (2022-2027)
  • Table 360. North America Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 361. North America Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 362. North America Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 363. North America Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 364. United States Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 365. United States Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 366. United States Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 367. United States Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 368. Canada Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 369. Canada Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 370. Canada Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 371. Canada Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 372. Mexico Vaccine Delivery Devices, by Type USD Million (2022-2027)
  • Table 373. Mexico Vaccine Delivery Devices, by Application USD Million (2022-2027)
  • Table 374. Mexico Vaccine Delivery Devices, by Administration USD Million (2022-2027)
  • Table 375. Mexico Vaccine Delivery Devices, by End User USD Million (2022-2027)
  • Table 376. Vaccine Delivery Devices Sales: by Type(K Units)
  • Table 377. Vaccine Delivery Devices Sales Syringes , by Region K Units (2022-2027)
  • Table 378. Vaccine Delivery Devices Sales Jet Injectors , by Region K Units (2022-2027)
  • Table 379. Vaccine Delivery Devices Sales Other Devices , by Region K Units (2022-2027)
  • Table 380. Vaccine Delivery Devices Sales: by Application(K Units)
  • Table 381. Vaccine Delivery Devices Sales Intradermal Vaccination , by Region K Units (2022-2027)
  • Table 382. Vaccine Delivery Devices Sales Intramuscular Vaccination , by Region K Units (2022-2027)
  • Table 383. Vaccine Delivery Devices Sales Subcutaneous Vaccination , by Region K Units (2022-2027)
  • Table 384. Vaccine Delivery Devices Sales Others , by Region K Units (2022-2027)
  • Table 385. Vaccine Delivery Devices Sales: by End User(K Units)
  • Table 386. Vaccine Delivery Devices Sales Hospitals , by Region K Units (2022-2027)
  • Table 387. Vaccine Delivery Devices Sales Clinics , by Region K Units (2022-2027)
  • Table 388. Vaccine Delivery Devices Sales Others , by Region K Units (2022-2027)
  • Table 389. South America Vaccine Delivery Devices Sales, by Country K Units (2022-2027)
  • Table 390. South America Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 391. South America Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 392. South America Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 393. South America Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 394. Brazil Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 395. Brazil Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 396. Brazil Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 397. Brazil Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 398. Argentina Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 399. Argentina Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 400. Argentina Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 401. Argentina Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 402. Rest of South America Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 403. Rest of South America Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 404. Rest of South America Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 405. Rest of South America Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 406. Asia Pacific Vaccine Delivery Devices Sales, by Country K Units (2022-2027)
  • Table 407. Asia Pacific Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 408. Asia Pacific Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 409. Asia Pacific Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 410. Asia Pacific Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 411. China Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 412. China Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 413. China Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 414. China Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 415. Japan Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 416. Japan Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 417. Japan Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 418. Japan Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 419. India Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 420. India Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 421. India Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 422. India Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 423. South Korea Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 424. South Korea Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 425. South Korea Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 426. South Korea Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 427. Taiwan Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 428. Taiwan Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 429. Taiwan Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 430. Taiwan Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 431. Australia Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 432. Australia Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 433. Australia Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 434. Australia Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 435. Rest of Asia-Pacific Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 436. Rest of Asia-Pacific Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 437. Rest of Asia-Pacific Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 438. Rest of Asia-Pacific Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 439. Europe Vaccine Delivery Devices Sales, by Country K Units (2022-2027)
  • Table 440. Europe Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 441. Europe Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 442. Europe Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 443. Europe Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 444. Germany Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 445. Germany Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 446. Germany Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 447. Germany Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 448. France Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 449. France Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 450. France Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 451. France Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 452. Italy Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 453. Italy Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 454. Italy Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 455. Italy Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 456. United Kingdom Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 457. United Kingdom Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 458. United Kingdom Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 459. United Kingdom Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 460. Netherlands Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 461. Netherlands Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 462. Netherlands Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 463. Netherlands Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 464. Rest of Europe Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 465. Rest of Europe Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 466. Rest of Europe Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 467. Rest of Europe Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 468. MEA Vaccine Delivery Devices Sales, by Country K Units (2022-2027)
  • Table 469. MEA Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 470. MEA Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 471. MEA Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 472. MEA Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 473. Middle East Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 474. Middle East Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 475. Middle East Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 476. Middle East Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 477. Africa Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 478. Africa Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 479. Africa Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 480. Africa Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 481. North America Vaccine Delivery Devices Sales, by Country K Units (2022-2027)
  • Table 482. North America Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 483. North America Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 484. North America Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 485. North America Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 486. United States Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 487. United States Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 488. United States Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 489. United States Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 490. Canada Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 491. Canada Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 492. Canada Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 493. Canada Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 494. Mexico Vaccine Delivery Devices Sales, by Type K Units (2022-2027)
  • Table 495. Mexico Vaccine Delivery Devices Sales, by Application K Units (2022-2027)
  • Table 496. Mexico Vaccine Delivery Devices Sales, by Administration K Units (2022-2027)
  • Table 497. Mexico Vaccine Delivery Devices Sales, by End User K Units (2022-2027)
  • Table 498. Vaccine Delivery Devices: by Type(USD/Units)
  • Table 499. Research Programs/Design for This Report
  • Table 500. Key Data Information from Secondary Sources
  • Table 501. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Vaccine Delivery Devices: by Type USD Million (2016-2021)
  • Figure 5. Global Vaccine Delivery Devices: by Application USD Million (2016-2021)
  • Figure 6. Global Vaccine Delivery Devices: by End User USD Million (2016-2021)
  • Figure 7. South America Vaccine Delivery Devices Share (%), by Country
  • Figure 8. Asia Pacific Vaccine Delivery Devices Share (%), by Country
  • Figure 9. Europe Vaccine Delivery Devices Share (%), by Country
  • Figure 10. MEA Vaccine Delivery Devices Share (%), by Country
  • Figure 11. North America Vaccine Delivery Devices Share (%), by Country
  • Figure 12. Global Vaccine Delivery Devices: by Type K Units (2016-2021)
  • Figure 13. Global Vaccine Delivery Devices: by Application K Units (2016-2021)
  • Figure 14. Global Vaccine Delivery Devices: by End User K Units (2016-2021)
  • Figure 15. South America Vaccine Delivery Devices Share (%), by Country
  • Figure 16. Asia Pacific Vaccine Delivery Devices Share (%), by Country
  • Figure 17. Europe Vaccine Delivery Devices Share (%), by Country
  • Figure 18. MEA Vaccine Delivery Devices Share (%), by Country
  • Figure 19. North America Vaccine Delivery Devices Share (%), by Country
  • Figure 20. Global Vaccine Delivery Devices: by Type USD/Units (2016-2021)
  • Figure 21. Global Vaccine Delivery Devices share by Players 2021 (%)
  • Figure 22. Global Vaccine Delivery Devices share by Players (Top 3) 2021(%)
  • Figure 23. Global Vaccine Delivery Devices share by Players (Top 5) 2021(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. PharmaJet, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. PharmaJet, Inc. (United States) Revenue: by Geography 2021
  • Figure 27. Vaxxas (United States) Revenue, Net Income and Gross profit
  • Figure 28. Vaxxas (United States) Revenue: by Geography 2021
  • Figure 29. Gerresheimer AG(Germany) Revenue, Net Income and Gross profit
  • Figure 30. Gerresheimer AG(Germany) Revenue: by Geography 2021
  • Figure 31. Schott AG (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Schott AG (Germany) Revenue: by Geography 2021
  • Figure 33. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 34. 3M (United States) Revenue: by Geography 2021
  • Figure 35. Corium International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Corium International, Inc. (United States) Revenue: by Geography 2021
  • Figure 37. Becton Dickinson & Company (United States) Revenue, Net Income and Gross profit
  • Figure 38. Becton Dickinson & Company (United States) Revenue: by Geography 2021
  • Figure 39. Bioject Medical Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Bioject Medical Technologies, Inc. (United States) Revenue: by Geography 2021
  • Figure 41. Global Vaccine Delivery Devices: by Type USD Million (2022-2027)
  • Figure 42. Global Vaccine Delivery Devices: by Application USD Million (2022-2027)
  • Figure 43. Global Vaccine Delivery Devices: by End User USD Million (2022-2027)
  • Figure 44. South America Vaccine Delivery Devices Share (%), by Country
  • Figure 45. Asia Pacific Vaccine Delivery Devices Share (%), by Country
  • Figure 46. Europe Vaccine Delivery Devices Share (%), by Country
  • Figure 47. MEA Vaccine Delivery Devices Share (%), by Country
  • Figure 48. North America Vaccine Delivery Devices Share (%), by Country
  • Figure 49. Global Vaccine Delivery Devices: by Type K Units (2022-2027)
  • Figure 50. Global Vaccine Delivery Devices: by Application K Units (2022-2027)
  • Figure 51. Global Vaccine Delivery Devices: by End User K Units (2022-2027)
  • Figure 52. South America Vaccine Delivery Devices Share (%), by Country
  • Figure 53. Asia Pacific Vaccine Delivery Devices Share (%), by Country
  • Figure 54. Europe Vaccine Delivery Devices Share (%), by Country
  • Figure 55. MEA Vaccine Delivery Devices Share (%), by Country
  • Figure 56. North America Vaccine Delivery Devices Share (%), by Country
  • Figure 57. Global Vaccine Delivery Devices: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • PharmaJet, Inc. (United States)
  • Vaxxas (United States)
  • Gerresheimer AG(Germany)
  • Schott AG (Germany)
  • 3M (United States)
  • Corium International, Inc. (United States)
  • Becton Dickinson & Company (United States)
  • Bioject Medical Technologies, Inc. (United States)
Select User Access Type

Key Highlights of Report


Feb 2022 238 Pages 75 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Vaccine Delivery Devices Quantitative research analysis
Global Vaccine Delivery Devices Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as PharmaJet, Inc. (United States), Vaxxas (United States), Gerresheimer AG(Germany), Schott AG (Germany), 3M (United States), Corium International, Inc. (United States), Becton Dickinson & Company (United States) and Bioject Medical Technologies, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Analysts at AMA estimates Vaccine Delivery Devices Market to reach USD Million by 2027.

Know More About Global Vaccine Delivery Devices Report?

Have a Query? Click Here

Other Related Reports

Cardiac Catheters Comprehensive Study by Type (Diagnostic Cardiac Catheters, Guiding Cardiac Catheters), Application (Diabetes, Renal failure, Cardiovascular diseases, Minimally invasive), Material (...
$ 3650
Perfusion Systems Comprehensive Study by Type (Bioreactor Perfusion Systems, Microfluidic Perfusion Systems, Gravity Or Pressure-Driven Perfusion Systems, Small-Mammal Organ Perfusion Systems), Appli...
$ 3750
Invisalign System Comprehensive Study by Type (Mouth Invisalign System, Skeleton Invisalign System), Application (Children, Adults, Old Men), Distribution Channel (Direct Sale, Laboratories, Other) P...
$ 3500
Gynecology Surgical Instruments Comprehensive Study by Type (Forceps(Allis Forceps, Artery Forceps, Other Forceps), Vaginal Speculums {Sims, Cusco, Other (Graves, Pediatric, and Pederson)}, Scissors,...
$ 3750
Emergency Evacuation Chair Comprehensive Study by Type (Standard Chai, Stair Climbing Chair, Sled Evacuation Chair, Multi-purpose Chair), Application (Household, Commercial Building, Transportation, ...
$ 3650
Rectoscopes Endoscope Comprehensive Study by Patient Type (Adult, Pediatric), Distribution Channel (Online, Offline), End User (Hospitals, Ambulatory Surgery Centers, Research Institutes, Others) Pla...
$ 3500